Right now shoppers can grab the Nike Air Force 1 '07 for as low as $70 and the Nike Air Force 1 Shadow for as low as $82.

NEW YORK CITY, NY / ACCESS Newswire / January 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CARGO ...

Benchmark upgraded Meta Platforms (META) to Buy from Hold with a $820 price target, citing a "strong" 2025 core business ...

H.C. Wainwright downgraded Cargo Therapeutics (CRGX) to Neutral from Buy without a price target The company’s FIRCE-1 trial was discontinued ...

Investing.com -- Shares of CARGO Therapeutics , Inc. (NASDAQ: CRGX) plummeted 75% following the company's decision to discontinue its Phase 2 clinical trial for firicabtagene autoleucel, citing ...

CAR T–focused biotech Cargo Therapeutics surprised and disappointed analysts when it announced that it would discontinue a mid-stage trial of its lead program, firi-cel.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CARGO Therapeutics, Inc. ("CARGO" or "the Company") for ...

The DJS Law Group announces that it is investigating claims on behalf of investors of CARGO Therapeutics, Inc. ("CARGO" or "the Company") for violations of the securities ...

Truist Securities revised its position on Cargo Therapeutics (NASDAQ:CRGX), currently trading at $13.19 with a market ...

Piper Sandler adjusted its stance on Cargo Therapeutics (NASDAQ:CRGX), downgrading the stock from Overweight to Neutral and ...

The changes will extend the company's cash runway, enabling it to advance a tri-specific CAR T-cell candidate and its allogeneic cell therapy platform.

This article has no body content. Login to continue reading Login Sign up for complimentary access Sign Up Now Close ...